Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants
Article in Frontiers in Pediatrics (January 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Article in Frontiers in Pediatrics (January 2024)
Preprint in Research Square (January 2024)
Article in PLOS ONE (August 2023)